Lisofylline, a Novel Antiinflammatory Compound, Protects Mesangial Cells from Hyperglycemia- and Angiotensin II-Mediated Extracellular Matrix Deposition

Endocrinology

Volumn 144, Issue 12, 2003, Pages 5227-5231

  Bolick, David T ^a   Hatley, Melissa E ^a   Srinivasan, Suseela ^a   Hedrick, Catherine C ^a   Nadler, Jerry L ^a  

^a UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANTIINFLAMMATORY AGENT; CANCER GROWTH FACTOR; COLLAGEN TYPE 4; CYCLIC AMP; FIBRONECTIN; GLUCOSE; GROWTH FACTOR; LAMININ; LISOFYLLINE; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; CULTURE MEDIUM; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE;

ANGIOTENSIN II; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; GENE EXPRESSION; GLOMERULAR MESANGIUM; GLUCOSE; HUMANS; HYPERGLYCEMIA; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PENTOXIFYLLINE; PHOSPHORYLATION; TRANSFORMING GROWTH FACTOR BETA; VASOCONSTRICTOR AGENTS;

EID: 0344394282     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0739     Document Type: Article

References (38)

1. Pylypchuk G, Beaubien E 2000 Diabetic nephropathy. Prevention and early referral. Can Fam Physician 46:636-642
2. Sterzel RB, Schulze-Lohoff E, Marx M 1993 Cytokines and mesangial cells. Kidney Int Suppl 39:S26-S31
3. McLennan SV, Death AK, Fisher EJ, Williams PF, Yue DK, Turtle JR 1999 The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy. Cell Mol Biol (Noisy-le-grand) 45:123-135
4. Hoffman BB, Sharma K, Ziyadeh FN 1998 Potential role of TGF-β in diabetic nephropathy. Miner Electrolyte Metab 24:190-196
5. Mansch GM, Wagner C, Burger A, Dong W, Staehler G, Stoeck M1995 Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor β (TGF β) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA. J Cell Physiol 163:451-457
6. Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC 2003 TGF-β signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284:F243-F252
7. Poncelet AC, de Caestecker MP, Schnaper HW 1999 The transforming growth factor-β/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 56:1354-1365
8. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A 2002 CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 62:1149-1159
9. Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW 1999 TGF-β1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int 56:1710-1720
10. Wahab NA, Yevdokimova N, Weston BS, Roberts T, Li XJ, Brinkman H, Mason RM 2001 Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359:77-87
11. Chen M, Yang Z, Wu R, Nadler JL 2002 Lisofylline, a novel antiinflammatory agent, protects pancreatic β-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism. Endocrinology 143:2341-2348
12. Bleich D, Chen S, Bursten SL, Nadler JL 1996 Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1β- induced dysfunction in cultured rat islets. Endocrinology 137:4871-4877
13. Yang ZD, Chen M, Wu R, McDuffie M, Nadler JL 2002 The anti-inflammatory compound lisofylline prevents type I diabetes in non-obese diabetic mice. Diabetologia 45:1307-1314
14. George CL, Fantuzzi G, Bursten S, Leer L, Abraham E 1999 Effects of lisofylline on hyperoxia-induced lung injury. Am J Physiol 276:L776-L785
15. Clarke E, Rice GC, Weeks RS, Jenkins N, Nelson R, Bianco JA, Singer JW 1996 Lisofylline inhibits transforming growth factor β release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in mice. Cancer Res 56:105-112
16. Bhat VB, Madyastha KM 2001 Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline. Biochem Biophys Res Commun 288:1212-1217
17. Brownlee M 2001 Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
18. Bursten SL, Federighi DA, Parsons P, Harris WE, Abraham E, Moore Jr EE, Moore FA, Bianco JA, Singer JW, Repine JE 1996 An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome. Crit Care Med 24:1129-1136
19. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC 1977 Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 233:F366-F372
20. Michaelson JE, Ritzenthaler JD, Roman J 2002 Regulation of serum-induced fibronectin expression by protein kinases, cytoskeletal integrity, and CREB. Am J Physiol Lung Cell Mol Physiol 282:L291-L301
21. Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM 2003 RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 162:1123-1137
22. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, De LN, I, Zatz R 2003 Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 63:209-216
23. Twigg SM, Cao Z, McLennan SV, Burns WC, Brammar G, Forbes JM, Cooper ME 2002 Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 143:4907-4915
24. Cheng J, Grande JP 2002 Transforming growth factor-β signal transduction and progressive renal disease. Exp Biol Med (Maywood) 227:943-956
25. Liang Z, He Z 1998 [TGF-β1 antisense gene transfer into ito cells and suppressed extracellular matrix production]. Zhonghua Yi Xue Za Zhi 78:850-852 (Chinese)
26. Jiang W, Wang J, Yang C, Wang Y, Liu W, He B 2002 [Effects of antisense transforming growth factor beta receptor-I expressing plasmid on pig serum-induced rat liver fibrosis]. Zhonghua Yi Xue Za Zhi 82:1160-1164 (Chinese)
27. Rich JN 2003 The role of transforming growth factor-β in primary brain tumors. Front Biosci 8:E245-E260
28. Shah AH, Tabayoyong WB, Kundu SD, Kim SJ, Van Parijs L, Liu VC, Kwon E, Greenberg NM, Lee C 2002 Suppression of tumor metastasis by blockade of transforming growth factor β signaling in bone marrow cells through a retroviral-mediated gene therapy in mice. Cancer Res 62:7135-7138
29. Levings MK, Bacchetta R, Schulz U, Roncarolo MG 2002 The role of IL-10 and TGF-β in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol 129:263-276
30. Abreu JG, Ketpura NI, Reversade B, De Robertis EM 2002 Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 4:599-604
31. Gore-Hyer E, Shegogue D, Markiewicz M, Lo S, Hazen-Martin D, Greene EL, Grotendorst G, Trojanowska M 2002 TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 283:F707-F716
32. Gupta S, Clarkson MR, Duggan J, Brady HR 2000 Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58:1389-1399
33. Weston BS, Wahab NA, Mason RM 2003 CTGF mediates TGF-β-induced fibronectin matrix deposition by upregularing active α5β1 integrin in human mesangial cells. J Am Soc Nephrol 14:601-610
34. Yu L, Hebert MC, Zhang YE 2002 TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J 21:3749-3759
35. Reddy MA, Adler SG, Kim YS, Lanting L, Rossi J, Kang SW, Nadler JL, Shahed A, Natarajan R 2002 Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol 283:F985-F994
36. Nahman Jr NS, Rothe KL, Falkenhain ME, Frazer KM, Dacio LE, Madia JD, Leonhart KL, Kronenberger JC, Stauch DA 1996 Angiotensin II induction of fibronectin biosynthesis in cultured human mesangial cells: association with CREB transcription factor activation. J Lab Clin Med 127:599-611
37. Kreisberg JI, Kreisberg SH 1995 High glucose activates protein kinase C and stimulates fibronectin gene expression by enhancing a cAMP response element. Kidney Int Suppl 51:S3-S11
38. Dean DC, McQuillan JJ, Weintraub S 1990 Serum stimulation of fibronectin gene expression appears to result from rapid serum-induced binding of nuclear proteins to a cAMP response element. J Biol Chem 265:3522-3527